Literature DB >> 10515872

Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice.

F E Nicolini1, T L Holyoake, J D Cashman, P P Chu, K Lambie, C J Eaves.   

Abstract

Comparative measurements of different types of hematopoietic progenitors present in human fetal liver, cord blood, and adult marrow showed a large (up to 250-fold), stage-specific, but lineage-unrestricted, amplification of the colony-forming cell (CFC) compartment in the fetal liver, with a higher ratio of all types of CFC to long-term culture-initiating cells (LTC-IC) and a lower ratio of total (mature) cells to CFC. Human fetal liver LTC-IC were also found to produce more CFC in LTC than cord blood or adult marrow LTC-IC, and more of the fetal liver LTC-IC-derived CFC were erythroid. Human fetal liver cells regenerated human multilineage hematopoiesis in NOD/SCID mice with the same kinetics as human cord blood and adult marrow cells, but sustained a high level of terminal erythropoiesis not seen in adult marrow-engrafted mice unless exogenous human erythropoietin (Epo) was injected. This may be due to a demonstrated 10-fold lower activity of murine versus human Epo on human cells, sufficient to distinguish between a differential Epo sensitivity of fetal and adult erythroid precursors. Examination of human LTC-IC, CFC, and erythroblasts generated either in NOD/SCID mice and/or in LTC showed the types of cells and hemoglobins produced also to reflect their ontological origin, regardless of the environment in which the erythroid precursors were generated. We suggest that ontogeny may affect the behavior of cells at many stages of hematopoietic cell differentiation through key changes in shared signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515872

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice.

Authors:  H Glimm; W Eisterer; K Lee; J Cashman; T L Holyoake; F Nicolini; L D Shultz; C von Kalle; C J Eaves
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Transcriptional environment and chromatin architecture interplay dictates globin expression patterns of heterospecific hybrids derived from undifferentiated human embryonic stem cells or from their erythroid progeny.

Authors:  Kai-Hsin Chang; Andy Huang; Hemei Han; Yi Jiang; Xiangdong Fang; Chao-Zhong Song; Steve Padilla; Hao Wang; Hongzhu Qu; John Stamatoyannopoulos; Qiliang Li; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2013-08-28       Impact factor: 3.084

3.  Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP)phenotype.

Authors:  N Uchida; T Fujisaki; A C Eaves; C J Eaves
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

4.  Comparison of Human Hematopoietic Reconstitution in Different Strains of Immunodeficient Mice.

Authors:  Ashley I Beyer; Marcus O Muench
Journal:  Stem Cells Dev       Date:  2016-10-27       Impact factor: 3.272

5.  Femoral Heads from Total Hip Arthroplasty as a Source of Adult Hematopoietic Cells.

Authors:  Anthony D Pomicter; Phillip M Clair; Dongqing Yan; William L Heaton; Anna M Eiring; Michael B Anderson; Stephen M Richards; Jeremy Gililland; Thomas O'Hare; Michael W Deininger
Journal:  Acta Haematol       Date:  2021-01-07       Impact factor: 2.195

6.  Recovery and Biodistribution of Ex Vivo Expanded Human Erythroblasts Injected into NOD/SCID/IL2Rγ mice.

Authors:  Barbara Ghinassi; Leda Ferro; Francesca Masiello; Valentina Tirelli; Massimo Sanchez; Giovanni Migliaccio; Carolyn Whitsett; Stefan Kachala; Isabelle Riviere; Michel Sadelain; Anna Rita Migliaccio
Journal:  Stem Cells Int       Date:  2011-08-16       Impact factor: 5.443

7.  Changes in the proliferative activity of human hematopoietic stem cells in NOD/SCID mice and enhancement of their transplantability after in vivo treatment with cell cycle inhibitors.

Authors:  J Cashman; B Dykstra; I Clark-Lewis; A Eaves; C Eaves
Journal:  J Exp Med       Date:  2002-11-04       Impact factor: 14.307

8.  The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells.

Authors:  John M Ninos; Leigh C Jefferies; Christopher R Cogle; William G Kerr
Journal:  J Transl Med       Date:  2006-02-16       Impact factor: 5.531

Review 9.  Developmental changes in hematopoietic stem cell properties.

Authors:  Michael R Copley; Connie J Eaves
Journal:  Exp Mol Med       Date:  2013-11-15       Impact factor: 8.718

10.  The adult livers of immunodeficient mice support human hematopoiesis: evidence for a hepatic mast cell population that develops early in human ontogeny.

Authors:  Marcus O Muench; Ashley I Beyer; Marina E Fomin; Rahul Thakker; Usha S Mulvaney; Masato Nakamura; Hiroshi Suemizu; Alicia Bárcena
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.